Common use of Sponsor Drug Clause in Contracts

Sponsor Drug. Sponsor will provide Institution with sufficient quantities of the Sponsor product that is being studied (“Sponsor Drug”) to conduct the Trial at no cost to the Institution and Principal Investigator. If required by the Protocol and unless otherwise agreed, Sponsor will also provide placebo or comparator drug (“Comparator Drug”) at no cost to the Institution and Principal Investigator.

Sponsor Drug. Sponsor will provide Institution with sufficient quantities of the Sponsor product that is being studied (“Sponsor Drug”) to conduct the Trial at no cost to the Institution and Principal InvestigatorTrial. If required by the Protocol and unless otherwise agreed, Sponsor will also provide placebo or comparator drug (“Comparator Drug”) at no cost to ). For the Institution and Principal Investigatoravoidance of doubt Sponsor will not provide any Sponsor Drug following completion of the Trial.

Sponsor Drug. Sponsor will provide Institution with sufficient quantities of the Sponsor product that is being studied (“Sponsor Drug”) to conduct the Trial at no cost to the Institution and Principal Investigator. If required by the Protocol and unless otherwise agreed, Sponsor will also provide placebo or comparator drug (“Comparator Drug”) at no cost to the Institution and Principal Investigator. Sponsor will ensure the issuing of approvals from State Institute of Drug Control and etics committees.

Sponsor Drug. Sponsor will provide Institution and/or Principal Investigator with sufficient quantities of the Sponsor product that is being studied (“Sponsor Drug”) to conduct the Trial at no cost to the Institution and Principal InvestigatorInstitution. If required by the Protocol and unless otherwise agreed, Sponsor will also provide placebo or comparator drug (“Comparator Drug”) at no cost to the Institution and Principal InvestigatorInstitution.

Sponsor Drug. Sponsor will provide Institution with sufficient quantities of the Sponsor product that is being studied (“Sponsor Drug”) Drug to conduct the Trial at no cost to the Institution and Principal Investigator. If required by the Protocol and unless otherwise agreed, Sponsor will also provide placebo or comparator drug (“Comparator Drug”) at no cost to the Institution and Principal Investigator.

Sponsor Drug. Sponsor will provide Institution Provider with sufficient quantities of the Sponsor product that is being studied (“Sponsor Drug”) to conduct the Trial at no cost to the Institution Provider and Principal Investigator. If required by the Protocol and unless otherwise agreed, Sponsor will also provide placebo or comparator drug (“Comparator Drug”) at no cost to the Institution Provider and Principal Investigator. 4.1.

Sponsor Drug. Sponsor will provide Institution with sufficient quantities of the Sponsor product that is being studied (“Sponsor Drug”) to conduct the Trial at no cost without charge to the Institution and Principal Investigator. If required by the Protocol and unless otherwise agreed, Sponsor will also provide placebo or comparator drug (“Comparator Drug”) at no cost without charge to the Institution and Principal Investigator.

Sponsor Drug. Sponsor will provide Institution with sufficient quantities of the Sponsor product that is being studied (“Sponsor Drug”) to conduct the Trial at no cost to the Institution and Principal Investigator. If required by the Protocol and unless otherwise agreed, Sponsor will also provide placebo or comparator drug (“Comparator Drug”) at no cost to the Institution and Principal Investigator. jsou v souladu s platnými zákony, nezávislou etickou komisí a/nebo RÚ. Smluvní strany dále zajistí, aby po celou dobu jeho provádění bylo klinického hodnocení pod trvalým dohledem NEK a/nebo RÚ.

Sponsor Drug. Sponsor will provide Institution with sufficient quantities of the Sponsor product that is being studied (“Sponsor Drug”) to conduct the Trial at no cost to the Institution and Principal Investigator. If required by the Protocol and unless otherwise agreed, Sponsor will also provide placebo or comparator drug (“Comparator Drug”) at no cost to the Institution and Principal Investigatorplatnosti smlouvy smlouvu ukončit.

Sponsor Drug. Sponsor will provide Institution with sufficient quantities of the Sponsor product that is being studied (“Sponsor Drug”) to conduct the Trial at no cost to the Institution and Principal Investigator. If required by the Protocol and unless otherwise agreed, Sponsor will also provide placebo or comparator drug (“Comparator Drug”). The Sponsor Drug (and, if applicable, the comparator drug) at no cost will be delivered to the Institution and Principal Investigatorhospital pharmacy of the Institution.

Sponsor Drug. Sponsor or its designee will provide Institution with sufficient quantities of the Sponsor product that is being studied (“Sponsor Drug”) to conduct the Trial at no cost to the Institution and Principal Investigator. If required by the Protocol and unless otherwise agreed, Sponsor or its designee will also provide placebo or comparator drug (“Comparator Drug”) at no cost to the Institution and Principal Investigator. The Sponsor Drug (and, if applicable, the comparator drug) will be delivered to the hospital pharmacy of the Institution.

Sponsor Drug. Sponsor will provide Institution to the Institution’s Pharmacy with sufficient quantities of the Sponsor product that is being studied (“Sponsor Drug”) to conduct the Trial at no cost to the Institution and Principal InvestigatorTrial. If required by the Protocol and unless otherwise agreed, Sponsor will also provide placebo or comparator drug (“Comparator Drug”) at no cost to the Institution and Principal Investigator).

Sponsor Drug. Sponsor will provide Institution with sufficient quantities of the Sponsor product that is being studied (“Sponsor Drug”) to conduct the Trial at no cost to the Institution and Principal InvestigatorTrial. If required by the Protocol and unless otherwise agreed, Sponsor will also provide placebo or comparator drug (“Comparator Drug”) at no cost to the Institution and Principal Investigator).

Sponsor Drug. Sponsor or their designee will provide Institution with sufficient quantities of the Sponsor product that is being studied (“Sponsor Drug”) to conduct the Trial at no cost to the Institution and Principal InvestigatorTrial. If required by the Protocol and unless otherwise agreed, Sponsor or their designee will also provide placebo or comparator drug (“Comparator Drug”) at no cost to the Institution and Principal Investigator).

Sponsor Drug. Sponsor or its designee will provide Institution and/or Principal Investigator with sufficient quantities of the Sponsor product that is being studied (“Sponsor Drug”) to conduct the Trial at no cost to the Institution and Principal InvestigatorInstitution. If required by the Protocol and unless otherwise agreed, Sponsor or its designee will also provide placebo or comparator drug (“Comparator Drug”) at no cost to the Institution and Principal InvestigatorInstitution.

Sponsor Drug. Sponsor will provide Institution and/or Principal Investigator with sufficient quantities of the Sponsor product that is being studied (“Sponsor Drug”) to conduct the Trial at no cost to the Institution and Principal InvestigatorInstitution. If required by the Protocol and unless otherwise agreed, Sponsor will also provide placebo or comparator drug (“Comparator Drug”) at no cost to the Institution and Principal InvestigatorInstitution. INC Research shall ensure distribution of Sponsor Drug shipment to the Institution´s pharmacy where the 2. Protokol Zdravotnické zařízení bude klinické hodnocení provádět v souladu s protokolem a platnými zákony. Předpokládaná doba trvání klinického hodnocení je přibližně do konce roku xxxx.

Sponsor Drug. Sponsor will provide Institution Healthcare Provider with sufficient quantities of the Sponsor product that is being studied (“Sponsor Drug”) to conduct the Trial at no cost to the Institution and Principal InvestigatorTrial. If required by the Protocol and unless otherwise agreed, Sponsor will also provide placebo or comparator drug (“Comparator Drug”) at no cost to ). For the Institution and Principal Investigatoravoidance of doubt Sponsor will not provide any Sponsor Drug following completion of the Trial.

Sponsor Drug. Sponsor will provide Institution free of charge with sufficient quantities of the Sponsor product that is being studied (“Sponsor Drug”) to conduct the Trial at no cost Trial. Sponsor will provide Institution free of charge with sufficient amount of study drug, which will be administered to the Institution and Principal Investigator. If required by the Protocol and unless otherwise agreed, Sponsor will also provide placebo or comparator drug (“Comparator Drug”) at no cost Trial subject according to the Institution and Principal InvestigatorProtocol.

Sponsor Drug. Sponsor will provide Institution with sufficient quantities of the Sponsor product that is being studied (“Sponsor Drug”) to conduct the Trial at no cost to the Institution and Principal InvestigatorTrial. If required by the Protocol and unless otherwise agreed, Sponsor will also provide placebo or comparator drug (“Comparator Drug”) at no cost to the Institution and Principal Investigator). 5.

Sponsor Drug. Sponsor will provide Institution and/or Principal Investigator with sufficient quantities of the Sponsor product that is being studied (“Sponsor Drug”) to conduct the Trial at no cost to the Institution and Principal InvestigatorInstitution. If required by the Protocol and unless otherwise agreed, Sponsor [through third party vendor] will also provide placebo or comparator drug (“Comparator Drug”) at no cost to the Institution and Principal InvestigatorInstitution.